 This trial is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control HbA1c using NovoRapid insulin aspart and Levemir insulin detemir after switch from human insulins for treatment of type 1 diabetes under normal clinical practice conditions in Romania. 